They are the following: 1. The PRC Drug Administration Law (2001). 2. Regulations for the Approval of New Drugs (1999). 3. Good Clinical Practices of Pharmaceutical Products (GCP) (1999). 4. Work Rules for Clinical Research of Drugs (2000). 5. Regulation for Monitoring Adverse Drug Reactions (1999).